Totally neoadjuvant chemoradiation therapy with mFOLFOX6 in locally advanced rectal cancer: A single-arm phase II study (FOTAC).

被引:1
|
作者
Deng, Yanhong
Zhang, Jianwei
Cai, Yue
Hu, Huabin
Xiao, Jian
机构
[1] Sun Yat Sen Univ, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
关键词
D O I
10.1200/JCO.2018.36.4_suppl.732
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
732
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial
    Chen, Jing
    Han, Yingyan
    Hu, Yingjie
    Feng, Xue
    Meng, Xiaolin
    Guo, Shuaiqingying
    Sun, Chaoyang
    Chen, Gang
    Li, Kezhen
    BMJ OPEN, 2023, 13 (05):
  • [32] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Shi, Jinming
    Li, Ning
    Tang, Yuan
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Ziyu
    Liu, Shixin
    Wang, Jun
    Wang, Wenling
    Zhu, Suyu
    Yang, Jialin
    Li, Yexiong
    Zhao, Dongbing
    Jin, Jing
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [33] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
    Jinming Shi
    Ning Li
    Yuan Tang
    Liming Jiang
    Lin Yang
    Shulian Wang
    Yongwen Song
    Yueping Liu
    Hui Fang
    Ningning Lu
    Shunan Qi
    Bo Chen
    Ziyu Li
    Shixin Liu
    Jun Wang
    Wenling Wang
    Suyu Zhu
    Jialin Yang
    Yexiong Li
    Dongbing Zhao
    Jing Jin
    BMC Gastroenterology, 22
  • [34] Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study
    Picardi, Vincenzo
    Deodato, Francesco
    Guido, Alessandra
    Giaccherini, Lucia
    Macchia, Gabriella
    Gambacorta, Maria A.
    Arcelli, Alessandra
    Farioli, Andrea
    Cellini, Francesco
    Cuicchi, Dajana
    Di Fabio, Francesca
    Poggioli, Gilberto
    Ardizzoni, Andrea
    Frezza, Giovanni
    Cilla, Savino
    Caravatta, Luciana
    Valentini, Vincenzo
    Fuccio, Lorenzo
    Morganti, Alessio G.
    ANTICANCER RESEARCH, 2016, 36 (08) : 4081 - 4087
  • [35] Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
    Marco, Michael R.
    Zhou, Lihong
    Patil, Sujata
    Marcet, Jorge E.
    Varma, Madhulika G.
    Oommen, Samuel
    Cataldo, Peter A.
    Hunt, Steven R.
    Kumar, Anjali
    Herzig, Daniel O.
    Fichera, Alessandro
    Polite, Blase N.
    Hyman, Neil H.
    Ternent, Charles A.
    Stamos, Michael J.
    Pigazzi, Alessio
    Dietz, David
    Yakunina, Yuliya
    Pelossof, Raphael
    Garcia-Aguilar, Julio
    DISEASES OF THE COLON & RECTUM, 2018, 61 (10) : 1146 - 1155
  • [36] Preliminary Results of a Prospective Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
    Tang, Y.
    Ma, H.
    Zhou, H.
    Liu, Z.
    Zhang, H.
    Zhang, W.
    Cai, Y.
    Li, Y.
    Wei, L. C.
    Liu, S.
    Wang, W.
    Fang, H.
    Song, Y. W.
    Chen, B.
    Lu, N. N.
    Jing, H.
    Qi, S. N.
    Zhang, W.
    Liu, Y.
    Wang, S.
    Wang, X.
    Li, Y.
    Jin, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E611 - E612
  • [37] CAMRELIZUMAB AND APATINIB COMBINED WITH CHEMOTHERAPY (MFOLFOX6) AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RIGHT-SIDED COLON CANCER (AMBITION)
    Tong, Zhou
    Lu, Sen
    Dai, Xiaomeng
    Cheng, Xiaobin
    Bao, Xuanwen
    Zhu, Xudong
    Cheng, Xiaofei
    Fu, Qihan
    Wang, Danyang
    Zhang, Hangyu
    Sheng, Qinsong
    Liu, Lulu
    Zhang, Guoliang
    Zheng, Yi
    Liu, Fanlong
    Zhao, Peng
    Chen, Wenbin
    Fang, Weijia
    Xu, Xiangmin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A443 - A443
  • [38] A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006
    Hashimoto, Tadayoshi
    Maruyama, Satoshi
    Takii, Yasumasa
    Mizusawa, Junki
    Kataoka, Tomoko
    Fukuda, Haruhiko
    Tsukamoto, Shunsuke
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Kanemitsu, Yukihide
    Colorectal Canc Study Grp, Colorectal Canc Study Grp
    Japan Clinical Oncology Grp, Japan Clinical Oncology Grp
    FUTURE ONCOLOGY, 2023, 19 (28) : 1897 - 1904
  • [39] A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer
    Willett, Christopher G.
    Duda, Dan G.
    Ancukiewicz, Marek
    Shah, Mira
    Czito, Brian G.
    Bentley, Rex
    Poleski, Martin
    Fujita, Hiroshi
    Lauwers, Gregory Y.
    Carroll, Madeline
    Tyler, Douglas
    Mantyh, Christopher
    Shellito, Paul
    Chung, Daniel C.
    Clark, Jeffrey W.
    Jain, Rakesh K.
    ONCOLOGIST, 2010, 15 (08): : 845 - 851
  • [40] mFOLFOX6 versus mFOLFOX6 D aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
    Hofheinz, R. -D.
    Herrle, F.
    Dechow, T.
    von Weikersthal, L. F.
    Welslau, M.
    Lettmaier, S.
    Burkart, C.
    Kubicka, S.
    Kochen, L.
    Merx, K.
    Krause, K.
    Ebert, M.
    Roedel, C.
    Fokas, E.
    Ghadimi, M.
    Reissfelder, C.
    Gaiser, T.
    ESMO OPEN, 2024, 9 (09)